Evonik Industries AG (EVKn)

Currency in EUR
18.340
-3.440(-15.79%)
Real-time Data·
Unusual trading volume
High dividend Yield
EVKn is included in our AI-picked strategies. See how they work
Fair Value
Day's Range
16.75021.860
52 wk Range
12.49022.520
Key Statistics
Prev. Close
21.78
Open
21.78
Day's Range
16.75-21.86
52 wk Range
12.49-22.52
Volume
3.52M
Average Volume (3m)
1.36M
1-Year Change
37.4063%
Book Value / Share
17.22
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
EVKn Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
19.555
Upside
+6.62%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year

Evonik Industries AG News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

2 Buy
7 Hold
3 Sell
Ratings:
12 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 19.555
(+6.62% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Jefferies
Hold21.00+14.82%20.00DowngradeNov 11, 2026
Berenberg
Hold22.50+23.02%20.00MaintainNov 04, 2026
Deutsche Bank
Hold22.00+20.28%18.00MaintainNov 04, 2026
JPMorgan
Sell15.00-17.99%14.00MaintainNov 04, 2026
Berenberg
Hold20.00+9.35%15.50UpgradeOct 05, 2026

Evonik Industries AG Earnings Call Summary for Q3/2026

  • Evonik's Q3 adjusted EBITDA surged 40% YoY to €629M, driven by pricing gains in advanced tech and C4 units plus cost reductions.
  • Management raised 2026 ROCE guidance above 8%; net debt fell €400M to €2.1B, with Moody's upgrading credit rating to Baa1.
  • Company expects weaker Q4 due to seasonality, rising costs, and methionine price normalization, but sees strong 2027 order books.
  • Evonik targets 11% ROCE by 2029 with sustained cash generation; maintaining €850M cash target and 40% conversion rate for 2026.
  • Restructuring program continues with 700+ job cuts; CEO Kullmann expected back early 2027, organic growth prioritized over M&A.
Last Updated: 2026-11-03, 06:18 a/m
Read Full Transcript

Earnings

Latest Release
Nov 04, 2026
EPS / Forecast
0.71 / 0.54
Revenue / Forecast
3.83B / 3.67B
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.37
Dividend Yield
4.59%
Industry Median 2.14%
Annualized payout
1.00
Paid annually
5-Years Growth
-2.76%
Growth Streak

EVKn Income Statement

Compare EVKn to Peers and Sector

Metrics to compare
EVKn
Peers
Sector
Relationship
P/E Ratio
58.3x18.7x3.6x
PEG Ratio
0.720.150.00
Price/Book
1.3x1.6x1.6x
Price / LTM Sales
0.7x1.0x1.1x
Upside (Analyst Target)
7.4%10.0%58.3%
Fair Value Upside
Unlock13.4%9.5%Unlock

Evonik Industries AG operates as a chemicals company in the Asia-Pacific, Europe, the Middle East, Africa, and the Americas. It operates through the Advanced Technologies, Custom Solutions, and Infrastructure segments. The Advanced Technologies segment provides polymers for medical applications; crosslinkers; hydrogen peroxide, a sterilizing agent for cleaning silicon wafers and a bleaching agent for the paper and textile industries; fumed and precipitated silicas and silanes for the automotive, tire, electronics, and cosmetics industries; and D-/L-methionine and lysine for animal nutrition. Its Custom Solutions segment provides additives for coatings, adhesives, sealants, polyurethane foams, and lubricants for the cosmetic, cleaning, and pharmaceutical industries. The Infrastructure segment engages in the infrastructure activities and offers butadiene, MTBE, butene-1, isononanol, and DINP for use in the plastic and packaging industries, production of rubber and fuels, and as plasticizers in the construction and automotive sectors. The company was founded in 1847 and is headquartered in Essen, Germany.

Industry
Chemicals
Employees
30319
Market
Germany

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
111.58M23.94%2.43B
Other Institutional Investors
235.45M50.52%5.13B
Public Companies & Retail Investors
118.98M25.53%2.59B
Total
466M100.00%10.15B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
RAG-Stiftung46.00%214,360,0004,668,761
Mondrian Investment Partners Limited5.00%23,297,313507,415

People Also Watch

94.20
KBX
-1.67%
17.554
ENAG
-0.88%
14.220
BKT
-0.63%
41.42
DTGGe
-0.38%

FAQ

What Is the Evonik (EVKn) Stock Price Today?

The Evonik stock price today is 18.340 EUR.

What Stock Exchange Does Evonik Trade On?

Evonik is listed and trades on the Frankfurt Stock Exchange.

What Is the Stock Symbol for Evonik?

The stock symbol for Evonik is "EVKn."

Does Evonik Pay Dividends? What’s The Current Dividend Yield?

The Evonik dividend yield is 4.6%%.

What Is the Evonik Market Cap?

As of today, Evonik market cap is 8.520B EUR.

What Is Evonik's Earnings Per Share (TTM)?

The Evonik EPS (TTM) is 0.37.

When Is the Next Evonik Earnings Date?

Evonik will release its next earnings report on Mar 04, 2027.

From a Technical Analysis Perspective, Is EVKn a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Evonik Stock Split?

Evonik has split 0 times.

How Many Employees Does Evonik Have?

Evonik has 30319 employees.

What is the current trading status of Evonik (EVKn)?

As of Nov 19, 2026, Evonik (EVKn) is trading at a price of 18.340 EUR, with a previous close of 21.780 EUR. The stock has fluctuated within a day range of 16.750 EUR to 21.860 EUR, while its 52-week range spans from 12.490 EUR to 22.520 EUR.

What Is Evonik (EVKn) Price Target According to Analysts?

The average 12-month price target for Evonik is 19.555 EUR, with a high estimate of 22.5 EUR and a low estimate of 15 EUR. 2 analysts recommend buying the stock, while 3 suggest selling, leading to an overall rating of Neutral. The stock has an +6.62% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.